Celldex Therapeutics DPO Ratio 2011-2026 | CLDX

Annual DPO Ratio Celldex Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.06 K	6.17 K	4.16 K	8.34 K	4.15 K	2.03 K	-	-	-	-	-	-	351	25.2	37.4

All numbers in USD currency

Maximum	Minimum	Average
8.34 K	25.2	3.26 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	405	$ 0.88	-2.05 %	$ 6.47 M	China
ACADIA Pharmaceuticals ACAD	75.2	$ 22.46	0.72 %	$ 3.72 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
CASI Pharmaceuticals CASI	123	-	-	$ 35.4 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
ChromaDex Corporation CDXC	76.3	-	-0.88 %	$ 598 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Aquestive Therapeutics AQST	395	$ 4.08	-0.61 %	$ 436 M	USA
Arcutis Biotherapeutics ARQT	133	$ 23.06	-1.54 %	$ 2.93 B	USA
Heron Therapeutics HRTX	91.4	$ 1.22	2.1 %	$ 203 M	USA
ImmuCell Corporation ICCC	19.5	$ 8.34	1.07 %	$ 75.3 M	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.49	4.58 %	$ 397 M	Britain
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	182	-	-	$ 546 M	USA